Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by REED, D. M.
Right arrow Articles by HOLDEN, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by REED, D. M.
Right arrow Articles by HOLDEN, E. M.
NEUROLOGY 1975;25:277
© 1975 American Academy of Neurology

Predicting the duration of Guam amyotrophic lateral sclerosis

DWAYNE M. REED, M.D., Ph.D., JACOB A. BRODY, M.D. and E. MICHAEL HOLDEN, M.D.

Epidemiology Branch, National Institute of Neurological Diseases and Stroke, Bethesda, Maryland, and the NINDS Research Center, Tamuning, Guam.

During the years of study of amyotrophic lateral sclerosis on Guam we have observed a wide range in clinical signs and rate of progression of the disease. Some patients died within 6 months of onset, while others have lived for 20 years. It was our assumption that some aspects of the early neurologic involvement would be related to length of survival, and hence be of prognostic value. We found that an early age at onset and male sex were associated with longer survival. The detailed analysis of degree of involvement of four major neurologic components of amyotrophic lateral sclerosis (progressive muscular atrophy, lateral sclerosis, bulbar paralysis, and pseudobulbar palsy) showed no meaningful pattern of association with duration of illness that could be useful in predicting the course.

Received for publication August 13, 1974.

Reprint requests should be addressed to Epidemiology Branch, C&FR, National Institute of Neurological Diseases and Stroke, Bethesda, MD 20014. Dr. Reed's present address is South Pacific Commission, Noumea, New Caledonia. Dr. Brady's present address is Atomic Bomb Casualty Commission, Hijiyama Park 5–2, Hiroshima 730, Japan. Dr. Holden's present address is 620 N. Almont Drive, Los Angeles, CA 90069.




This article has been cited by other articles:


Home page
Arch NeurolHome page
J. E. Kurent, B. R. Brooks, D. L. Madden, J. L. Sever, and W. K. Engel
CSF Viral Antibodies: Evaluation in Amyotrophic Lateral Sclerosis and Late-Onset Postpoliomyelitis Progressive Muscular Atrophy
Arch Neurol, May 1, 1979; 36(5): 269 - 273.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by AAN Enterprises, Inc.